SCHEMBL4458299

SCHEMBL4458299

COC(=O)c1ccc(OC)c(C(C)C)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.45
POLB P06746 2/20 0.45
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 2/20 0.42
USP2 O75604 1/20 0.42
PLK1 P53350 1/20 0.41
PKM P14618 1/20 0.40
GAA P10253 2/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HPGD P15428 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl 2,3,4-Trimethoxybenzoate SCHEMBL1434191 0.80 ALDH1A1 (0.57) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL6852879 0.78 CA1 (0.52) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL16513023 0.77 HTT (0.50) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL15713200 0.76 SMN1; SMN2 (0.40) KDM4EMAPTTDP1ALDH1A1HSD17B10
SCHEMBL24136599 0.74 LMNA (0.55) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL8894564 0.74 CA1 (0.50) KDM4EMAPTALDH1A1HSD17B10GAA
SCHEMBL1434290 0.74 MAPT (0.71) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL30466421 0.74 LMNA (0.55) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL23051546 0.74 MAPT (0.51) KDM4EPOLBMAPTTDP1ALDH1A1
SCHEMBL10691520 0.73 ALDH1A1 (0.39) KDM4EPOLBMAPTTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2073802-A1 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-07-01 EP disclosed
WO-2008044029-A1 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-04-17 WO disclosed